<<

48th EDTNA/ERCA International Conference September 14th-17th, 2019 Prague, Czech Republic

Conference Theme New Pathways in the Renal Setting-Caring Together by Integrating Modern Technology based on Knowledge & Education Final Programme CONTENT

Welcome Message from the President 3

Acknowledgement – Corporate Members 4

Acknowledgement – Conference Support 5

EDTNA/ERCA Booth 6

Conference Accreditation 6

The Conference Application – Instructions and Logistics 7

Conference Venue – Floor plans 8

Programme at a Glance 9

Scientific Programme Highlights 11

Scientific Programme 14

List of E-Posters 24

The Exhibition Floor Plan 30

The Exhibitors 31

Practical Conference Information 36

Opening Hours Summary 38

Good to know about Prague 38

Conference Contacts 39

2 WELCOME MESSAGE FROM THE PRESIDENT

Dear Colleagues, We are very happy to welcome you to Prague for the 48th EDTNA/ERCA Conference. Last time the Conference was held in Prague was in 2008, now, 11 years later we are back in Prague.

The Scientific Programme is well prepared and there will be several Workshops, Educational Sessions and Poster sessions. New this year are the Courses which will be interactive sessions allowing everybody to share their expertise.

We are, as an Association, in the forefront of Online Communication and it has been a focus for some years and will continue to be one of our focuses for the coming years. Take the opportunity to download the Conference App. It works both for iPhones and Androids.

We should never forget that face to face meetings gives us so much more than just to be in a Video call. It has an important role of educating, exchanging information and experience, utilizing the expertise of all of us i.e. health care professionals, service leaders, academics, researchers, care givers, people with renal disease and industry partners.

Take this opportunity being at the Conference, to share experience with other delegates from around the world focusing on Chronic Kidney Disease.

Together, let’s make this Conference into another EDTNA/ERCA success. Welcome to the 48th EDTNA/ERCA International Conference in Prague!

With very warm regards,

Edita Noruisiene EDTNA/ERCA President

3 ACKNOWLEDGEMENT – CORPORATE MEMBERS

Our Partners’ support, involvement and advice are greatly appreciated. Together we live and act according to our Mission and Vision and we are continuously working on achieving a high level of quality care for patients and their families. Being a Corporate Member sharing the key values, visions and missions of EDTNA/ERCA means that you are a very important part of the EDTNA/ERCA Community. Thank you for your continuous support.

4 ACKNOWLEDGEMENT – CONFERENCE SUPPORT

We would like to express our appreciation for the valuable support our Industry Partners’ bring by participating at the 48th EDTNA/ERCA International Conference. Our Partners support, involvement and advice are greatly appreciated. Thank You very much!

5 EDTNA/ERCA BOOTH

Don’t miss the opportunity to visit the EDTNA/ERCA booth located in the Exhibition Area. There will be a lot of opportunities for you to share your experience and knowledge with your friends and colleagues and learn more about our ongoing activities within the Association. Talk to our Volunteers who will share with you the work that they have achieved during the year. The EDTNA/ERCA Brand Ambassadors will be more than happy to help you with any language problems which might occur.

Two new Educational Books will be available for you to pick up at the Booth.

Get your copy of the New Book book by visiting the EDTNA/ERCA stand and

48th EDTNA/ERCA International Conference Caring for presentingPrague, Czech thisRepublic, Septembervoucher 14th - 17th, 2019 Patients with Polycystic - Kidney Disease A Guide for Nurses

Editors Anastasia Liossatou Maria Cruz Casal

Bring the vouchers included in the Conference Bag.

WELCOME!

CONFERENCE ACCREDITATION

Accreditation of Learning Hours The 48th EDTNA/ERCA International Conference in Prague is accredited. To ensure maximum quality in education and a professional Scientific Programme, EDTNA/ERCA has been granted International Continuing Nursing Education Credits (ICNEC) for the International Conference in Prague. The ICNEC are granted by the International Council of Nurses once strict admission conditions are fulfilled.

Participants of the conference will be awarded a maximum of 18 ICNECs. 1 credit is assigned for each 60minutes pent within the session halls, this is flexible and allows delegates to change between sessions and continue to accumulate credited time.

Please, note that not all sessions and workshops are accredited by ICN. If you are interested in receiving ICN credits, please see below the list of sessions not included in the accreditati on process: • S 02 Opening Ceremony • S 03 Corporate Education Session • S 08 Round Table Session – Empower PD Patients to Shared Care • W 04 Empower PD Patients to Self-Care – Validate patient´s skills to perform PD • Annual General Meeting 2019 • W 07 Workshop – Gaining EDTNA/ERCA Accreditation for your Renal Education Program – What’s Involved • W 08 Workshop – Home Hemodialysis – Getting a better quality of life for your patients • S 25 Closing Ceremony

Certificate The ICNEC certificate is granted by the ICN and requires an Attendance Verification Form. This Form is available at the Registration desk during the Conference and it is to be completed (address and email) and signed by the delegate and should be returned to the Registration staff. A Certificate detailing the number of credits achieved will be provided after the Conference by ICN.

A Certificate of Attendance will be provided by the Registration desk on the final day of the Conference as usual, or you can apply via email at [email protected] until November 30th, 2019.

6 THE CONFERENCE APPLICATION – INSTRUCTIONS & LOGISTICS

With the EDTNA/ERCA 2019 Conference App, you will have the opportunity to increase your interactivity and have the entire conference “in your hand”.

So, take advantage and download the App! Get the latest information and enhance your conference experience.

The EDTNA/ERCA 2019 Conference App gives access to: • Scientific Programme • Personal Planner / Congress Schedule • Venue Information • List of Posters • Exhibitors ... and much more!

Please follow the instructions to install the Conference Application on your mobile.

iPhone/Android – Go to the Appstore or Google play and download the Application. Name of the Application: EDTNA/ERCA 2019

If you have any difficulties in downloading the App or have any problems or questions about how to use it, please visit the EDTNA/ERCA booth and our EDTNA/ERCA Colleagues will support you.

BEST E-POSTER AND BEST SPEAKER VOTED BY THE DELEGATES!

Last year we have successfully implemented the Best E-Poster Award voted by the Delegates.

This year we have implemented a new award – Best Speaker Award!

The rating will be done by You – our Conference Delegate and it is up to you whom to give the Award to. It is available for all Conference participants via the Conference Application. Use the star rating to vote for the best E-Poster or for the best speaker.

Both awards according to the conference delegates evaluation will be presented during the Closing Ceremony.

Don’t miss out the chance to influence!

7 CONFERENCE VENUE – FLOOR PLANS

8 PROGRAMME AT A GLANCE

Saturday, September 14th, 2019 08:00–16:00 16:00–17:45 17:45–18:00 18:00-19:30 19:30-21:45 Registration Area Registration S 01 Plenary Session Coffee break S 02 Opening Welcome & Exhibition Hall A1+A2 Ceremony Opening Exhibition Area Exhibition

Sunday, September 15th, 2019 08:00–09:00 09:00–10:30 10:30–11:00 11:00–12:30 12:30–14:00 14:00–15:30 15:30–16:00 16:00–16:45 16:45–17:00 17:00–18:30 Registration Area Registration S 03 CES* – Coffee break S 05 DOPPS Clinical S 07 Polish Symposium S 09 Parallel Session Coffee break S 11 Parallel Session Break Annual General Medical Care Symposium 12:45–13:45 Haemodialysis 1 Transplantation Meeting 2019 The Future of Renal Update from the Hall A1 Nursing: Patient DOPPS Program: Centered Care in the Centering care around Digital Era patients S 04 Parallel Session S 06 Parallel Session S 08 Round Table S 10 Parallel Session S 12 Parallel Session Education The Patient Session – Baxter Home Therapies Open Forum 1 Hall A2 Experience Empower PD Patients to Shared Care 12:45–13:45 W 01 Workshop Lunch break W 02 Workshop Developing and Human Factors Hall A3 Maintaining Effective and Patient Safety: Teams Everybody’s Business W 03 Workshop Involving patients and family members from Hall B BAME/poor reached communities in clinical research C 01 Course C 02 Course Hygiene, Infection Hygiene, Infection Control and Control and Tower Prevention in Renal Prevention in Renal Care Care 14:00–14:45 Exhibition Area Exhibition

9 Monday, September 16th, 2019 08:00–09:00 09:00–10:30 10:30–11:00 11:00–12:30 12:30–14:00 14:00–15:30 15:30–16:00 16:00–17:30 17:30–18:00 Registration Area Registration S 13 Parallel Session Coffee break S 15 Parallel Session Lunch break S 18 Parallel Session Coffee break S 21 Parallel Session Needling with Plastic Vascular Access Haemodialysis 2 Ethical, Psychological Hall A1 Cannulae & Vascular and Social Impact Access of CKD S 14 Parallel Session S 16 Parallel Session S 17 Greek Forum S 19 Parallel Session S 22 Parallel Session European Kidney Peritoneal Dialysis Hypertension in Caring for the Open Forum 2 Hall A2 Health Alliance Chronic Kidney Well-being of Disease Renal Healthcare 12:45–13:45 Professionals W 04 Workshop W 06 Workshop Lunch break W 08 Workshop – Empower PD patients Uncovering the power Physidia Hall A3 to Self-Care – Validate of extra-ordinary Why opt for daily patient´s skills to leadership – The Home Haemodialysis? perform PD leadership Challenge 12:45–13:45 W 05 Workshop W 07 Workshop S 20 Parallel Session An Introduction to Gaining EDTNA/ERCA Join session Mindfulness Practices: Accreditation for ANNA-EDTNA/ERCA Hall B Managing Stress and your Renal Education Anxiety Program – What’s Involved 12:45–13:45 Tower 1 E-Poster Session A E-Poster Session B Lunch break E-Poster Session C E-Poster Session D C 04 Course C 06 Course Tower 2 Violence & Aggression Violence & Aggression in Renal Care in Renal Care C 03 Course C 05 Course Aesculap Critical states during Critical states during Academy a dialysis treatment a dialysis treatment Exhibition Area Exhibition

Tuesday, September 17th, 2019 08:30–10:00 10:00–10:15 10:15–11:45 11:45–12:00 12:00–13:00 13:00–14:00 Registration Area Registration S 23 Plenary Session Coffee break S 24 Plenary Session Break S 25 Closing Ceremony Hall A1 CKD & Conservative Risk Management Renal Care

10 SCIENTIFIC PROGRAMME HIGHLIGHTS

SCIENTIFIC PARALLEL SESSIONS Invited Guest Speakers discuss the latest developments in renal care during the plenary sessions. Quality Abstracts including the Short orals presentations have been selected for inclusion in the parallel sessions.

S 02 Opening Ceremony Improving Patient Outcomes Through Implementation Science: An Important Goal in Renal Care John Sedgewick (United Kingdom)

S 06 The Patient Experience Engaging the “poorly reached” in kidney research and awareness campaigns Neerja Jain (United Kingdom)

S 14 European Kidney Health Alliance Improving the life of kidney disease patients throughout Europe and the EU: the European Kidney Health Alliance Raymond Vanholder (Belgium)

S 23 CKD & Conservative Renal Care The Older Dialysis Patient: Issues and Concerns Alice Hellebrand (United States)

LUNCH TIME SYMPOSIA

S 07 Polish Symposium Vaccination in hemodialyzed patients Anna Klis (Poland)

Co-morbidity in hemodialyzed patients as an important aspect of nursing care Małgorzata Liber (Poland) Elżbieta Cepuchowicz (Poland)

Nephrological nurses and occupational exposure – how? when? why? Aneta Trzcinska (Poland)

S 17 Greek Forum Hypertension in Chronic Kidney Disease Vassilios Liakopoulos (Greece)

Blood Pressure measurement – technique data Marianna Eleftheroudi (Greece)

WORKSHOPS & ROUND TABLE SESSIONS

W 01 Workshop Developing and Maintaining Effective Teams John Sedgewick (United Kingdom)

W 02 Workshop Human Factors and Patient Safety: Everybody’s Business Lesley Bennet (United Kingdom) Karen Jenkins (United Kingdom)

W 03 Workshop Involving patients and family members from BAME/poor reached communities in clinical research Neerja Jain (United Kingdom)

11 W 04 Workshop

Empower PD patients to Self-Care – Validate patient´s skills to perform PD Maria Arminda Tavares (Portugal)

W 05 Workshop An Introduction to Mindfulness Practices: Managing Stress and Anxiety Clare McVeigh (United Kingdom)

W 06 Workshop Uncovering the power of extra-ordinary leadership – The leadership Challenge John Sedgewick (United Kingdom)

W 07 Workshop Gaining EDTNA/ERCA Accreditation for your Renal Education Program – What’s Involved John Sedgewick (United Kingdom) Theodora Khafkia ()

W 08 Workshop – Physidia

Home Haemodialysis – Getting a better quality of life for your patients Aziz Abercane (France) Veliana Todorova (France), Matt Willans (United Kingdom) Greig Johnstone (United Kingdom) Cedric Poulard, Physidia (France) Fredrik Thibblin (Sweden)

S 08 Round Table Session – Baxter

Empower PD patients to Shared Care Doctors Perspective Thierry Lobbedez (France)

Nurses Perspective Gail McMullan (United Kingdom)

The Perspective of the Multidisciplinary Team Maria Arminda Tavares (Portugal) Gail McMullan (United Kingdom) Aase Riemann (The ) Kalliopi-Anna Poulia (Greece) Mike Kelly (Belgium) Thierry Lobbedez (France)

12 COURSES

C 01; C 02 Course Hygiene, Infection Control and Prevention in Renal Care Paul Challinor (United Kingdom) Ivana Bartakova (Czech Republic)

C 03; C 05 Course Critical states during a dialysis treatment Michael Stern (Czech Republic)

C 04; C 06 Course Violence & Aggression in Renal Care Jaroslav Pekara (Czech Republic)

CORPORATE EDUCATION SESSION

S 03 Corporate Education Session –

The Future of Renal Nursing: Patient Centered Care in the Digital Era Maria Teresa Parisotto (Germany) Ivana Lupomeska (Czech Republic) Raquel Ribeiro (Portugal) Marjelka Trkulja (Croatia) Niklas Best (Germany)

DOPPS SYMPOSIUM

S 05 DOPPS Clinical Symposium

Update from the DOPPS Program: Centering care around patients Anna Marti i Monros (Spain) Michel Roden (Belgium) Marisa Pegoraro (Italy) Jennie King (United Kingdom)

13 Saturday Sunday Monday Tuesday SCIENTIFIC PROGRAMME

Saturday, September 14th, 2019 16:00–17:45 Hall A1 + A2 S 01 Plenary Session The EDTNA/ERCA Collaboration Program – Creating a long-term sustainable Association together with the Multidisciplinary Team Chairs: Edita Noruisiene, EDTNA/ERCA President (Lithuania) Anki Davidson, EDTNA/ERCA Marketing Director (Sweden) Awareness, understanding and treatment practices among health care professionals involved in managing cachexia in patients with end-stage renal disease A joint project between EDTNA/ERCA Research Group & Queen’s University, Belfast (UK) Ilaria de Barbieri, EDTNA/ERCA (Italy) Assessment for Malnutrition – Subjective Global Assessment (SGA) for dialysis patients A joint project between EDTNA/ERCA & B. Braun Martin Meier, B. Braun (Germany) Kalliopi-Anna Poulia, EDTNA/ERCA (Greece) Home Haemodialysis – From the Patient Perspective A joint project between EDTNA/ERCA & NxStage Siobhan Gladding, NxStage (United Kingdom) Henning Sondergaard, (Denmark) Venous Needle Dislodgement – Is it necessary to report? A joint project between EDTNA/ERCA & Redsense Medical Sebastien Bollue, Redsense Medical (Sweden) Tai Mooi Ho Wong, EDTNA/ERCA (Spain) Cannulation Devices across Europe and its Implications – The final result of an international Survey A joint project between EDTNA/ERCA & Andy Cox, Medtronic (United Kingdom) Maria Teresa Parisotto, EDTNA/ERCA (Germany) 17:45–18:00 Coffee break – Saturday, September 14th, 2019 18:00–19:30 S 02 Opening Ceremony Conférencier and Master of the Opening Ceremony: Ilaria de Barbieri, (Italy)

Guest Speaker lecture Improving Patient Outcomes Through Implementation Science: An Important Goal in Renal Care John Sedgewick (United Kingdom)

19:30 Welcome & Exhibition Opening

14 Saturday Sunday Monday Tuesday

Sunday, September 15th, 2019 09:00–10:30 Hall A1 Hall A2 S 03 Corporate Education Session – S 04 Parallel Session Fresenius Medical Care Education The Future of Renal Nursing: Patient Chairs: John Sedgewick Centered Care in the Digital Era (United Kingdom) & Nicola Thomas Chair: Raquel Ribeiro (Portugal) (United Kingdom) Holistic care yesterday, today O 01 and tomorrow in renal nursing Post test evaluation of a patient decision Maria Teresa Parisotto (Germany) aid with decision coaching for dialysis choice Jeanette Finderup (Denmark) The power of information in the digital O 02 nursing era Importance of an educational program Ivana Lupomeska (Czech Republic) in the control of hyperphosphatemia Márcia Cuba (Portugal) Digital opportunities to improve patient O 03 care Investigation of factors affecting dialysis Niklas Best (Germany) technician students’ learning styles and attitudes towards technology Fatma Kaban (Turkey) Translating digital opportunities into O 04 improved patient care An innovative pathway: community, Raquel Ribeiro (Portugal) local authority & charity partnership addresses barriers to organ donation Neerja Jain (United Kingdom) Empowering renal nurses for the future SO 05 Marjelka Trkulja (Croatia) Management of urinary tract infections in dialysis patient- A case study David Meshman (Israel) Discussion panel SO 06 Educational and follow up program for dialysis patients’ treatment outcomes João Pedro Barros (Portugal) SO 07 National audit of dialysis units in the Kingdom of Saudi Arabia Reem Alhameedi (Saudi Arabia) 10:30–11:00 Coffee break – Sunday, September 15th, 2019

15 Saturday Sunday Monday Tuesday

11:00–12:30 Hall A1 Hall A2 Hall A3 S 05 DOPPS Clinical Symposium S 06 Parallel Session W 01 Workshop Update from the DOPPS Program: The Patient Experience Developing and Maintaining Effective Centering care around patients Chairs: Mike Kelly (Ireland) Teams Chairs: Edita Noruisiene (Lithuania) & Karen Jenkins (United Kingdom) Chair: John Sedgewick (United Kingdom) & Anna Marti i Monros (Spain) Perceptions about the dialysis modality Guest Speaker lecture decision process among peritoneal Engaging the “poorly reached” dialysis and in-centre haemodialysis in kidney research and awareness patients campaigns Anna Marti i Monros (Spain) Neerja Jain (United Kingdom) Coping with kidney disease – qualitative O 08 findings from the Empowering Patients Quality of life in haemodialysis on Choices for Renal Replacement and conservative management patients Therapy (EPOCH-RRT) study Clare McKeaveney (United Kingdom) Michel Roden (Belgium) Patient perspectives on the choice SO 10 of dialysis modality: Results Evaluating patient and carer perspectives from the Empowering Patients on Choices of a kidney supportive care program for Renal Replacement Therapy Ann Bonner (Australia) (EPOCH-RRT) study Marisa Pegoraro (Italy) Associations of self-reported physical SO 11 activity types and levels with quality Pain management using music therapy of life, depression symptoms, in a dialysis unit and mortality in haemodialysis patients Florence Fernandes (France) Jennie King (United Kingdom) Panel Discussion – All speakers SO 12 and audience Transplant education programme – patient experience Juby Susan Thomas (Ireland) 12:30–14:00 Lunch break – Sunday, September 15th, 2019 Hall A1 Hall A2 S 07 Lunch Symposium S 08 Round Table Session – Baxter Polish Symposium Empower PD Patients to Shared Care 12:45–13:45 12:45–13:45 Chairs: Aneta Trzcinska (Poland) & Anna Chair: Maria Arminda Tavares (Portugal) Klis (Poland) (Session in Polish language) Doctors Perspective Session Welcome Thierry Lobbedez (France) Ilaria de Barbieri (Italy) Nurses Perspective Vaccination in hemodialyzed patients Gail McMullan (United Kingdom) Anna Klis (Poland) The Perspective of the Multidisciplinary Co-morbidity in hemodialyzed patients Team as an important aspect of nursing care Panel Discussion: Maria Arminda Tavares Małgorzata Liber (Poland) (Portugal), Thierry Lobbedez (France), Elżbieta Cepuchowicz (Poland) Gail McMullan (United Kingdom), Aase Riemann (The Netherlands), Kalliopi- Nephrological nurses and occupational Anna Poulia (Greece), Mike Kelly exposure – how? when? why? (Ireland) Aneta Trzcinska (Poland)

16 Saturday Sunday Monday Tuesday

14:00–15:30 Hall A1 Hall A2 Hall A3 Hall B Tower S 09 Parallel Session S 10 Parallel Session W 02 Workshop W 03 Workshop C 01 Course Haemodialysis 1 Home Therapies Human Factors and Patient Safety: Involving patients and family members Hygiene, Infection Control Chairs: Susan Rogers (The Netherlands) Chairs: Michael Roden (Belgium) Everybody’s Business from BAME/poor reached communities and Prevention in Renal Care & Hanadi Mezher (Lebanon) & Linsey Worsey (United Kingdom) Chairs: Lesley Bennet (United Kingdom) in clinical research 14:00–14:45 Karen Jenkins (United Kingdom) Chair: Neerja Jain (United Kingdom) Lectors: Paul Challinor (United Kingdom) & Ivana Bartakova (Czech Republic) O 13 O 20 Quality of life, emotional states and pain Buttonhole in Daily Home Hemodialysis in patients with chronic haemodialysis (DHHD): A rigorous practice for an treatment optimal long-term result Afra Masià-Plana (Spain) Francoise Delestre (France) O 14 O 21 Cachexia and end-stage renal disease: Nursing perception of the selection results from a cross-sectional analysis of existing hemodialysis patients Clare McKeaveney (United Kingdom) for home therapies Jacqueline Cainglet (United Arab Emirates) O 15 O 22 Quality of life in the aspect of dental No site infection with buttohhole problems in haemodialysis patients needling technique when implementing Anna Kliś (Poland) double anti-sepsia two years experience Anna Marti i Monros (Spain) O 16 O 23 Intradialytic exercise and physical Improving care and overcoming barriers activity levels: effects beyond the dialysis through learnings from our patients/ period! families Rui Sousa (Portugal) Ethel Macatangay (Canada) SO 17 SO 24 Does intravascular volume status Sharing practices and standards measured by inferior vena cava to improve sustainability of home ultrasound correlate with bioimpedance haemodialysis globally. SIGNhd Global. spectroscopy? Laura Thompson (United Kingdom) Ulrich Steinwandel (Australia) SO 18 SO 25 Measurement of vascular access To overcome barriers for self needling flow and recirculation in chronic Anna Marti i Monros (Spain) haemodialysis patients Erika Petrovic (Slovenia) SO 26 The Journey Home: Growing a home hemodialysis program while fostering professional relationships Kathleen Brown (Canada) 15:30–16:00 Coffee break – Sunday, September 15th, 2019

17 Saturday Sunday Monday Tuesday

16:00–16:45 Hall A1 Hall A2 Tower S 11 Parallel Session S 12 Parallel Session C 02 Course Transplantation Open Forum 1 Hygiene, Infection Control Chairs: Marie Richards (United Arab Chairs: Ilaria de Barbieri (Italy) and Prevention in Renal Care Emirates) & Stavroula Vovlianou & Veronica Strini (Italy) Lectors: Paul Challinor (United Kingdom) (Greece) & Ivana Bartakova (Czech Republic) O 27 O 31 Renal nurses’ perceptions regarding Nursing role in identification of patients cadaveric ikdney transplantation in Abu at risk of Acute Kidney Injury in Dhabi AbuDhabi Mesele Emily Ralyona (United Arab Madeline Manuel (United Arab Emirates) Emirates) SO 29 O 32 The phenomenon of urinary tract Illness experience in nephrotic syndrome infection experienced by women Anneli Jönsson (Sweden) with a kidney transplant Lotte Løntoft Mathiesen (Denmark) SO 30 O 33 Evaluation of barriers to kidney What do patients know and remember transplantation in a dialysis unit about their lives in hemodialysis? Rawia Badran (Israel) A multicentric study Donato Leopaldi (Italy) 16:45–17:00 Break – Sunday, September 15th, 2019 17:00–18:30 Hall A1 Annual General Meeting 2019 Chair: Edita Noruisiene (Lithuania) Welcome by the President Agenda: Introduction Electronic Voting explanation and test, Check for Quorum of Members Activity Report 2018 Financial Report 2018 Questions, Discussion and Approval Motions EC Elections and EC Committee 2019 – 2020 Reward and Recognition Strategy 2019–2025 Date and Venue of AGM 2020 Closing

18 Saturday Sunday Monday Tuesday

Monday, September 16th, 2019 09:00–10:30 Hall A1 Hall A2 Hall A3 Hall B Tower 1 Aesculap Academy S 13 Parallel Session S 14 Parallel Session W 04 Workshop – Baxter W 05 Workshop E-Poster Session A C 03 Course Needling with Plastic Cannulae European Kidney Health Alliance Empower PD patients to Self-Care – An Introduction to Mindfulness Chairs: Michael Roden (Belgium) Critical states during a dialysis & Vascular Access Chairs: Alois Gorke (Germany) Validate patient´s skills to perform PD Practices: Managing Stress and Anxiety & Aneta Trzcinska (Poland) treatment Chairs: Marianna Eleftheroudi (Greece) & Anna Klis (Poland) Chairs: Susan Rogers (The Netherlands) Chair: Clare McVeigh (United Kingdom) Lector: Michael Stern (Czech Republic) & Marisa Pegoraro (Italy) & Aase Riemann (The Netherlands) O 34 Guest Speaker lecture Practical Module E-P 001 Analysis of the experience in the use Improving the life of kidney disease All participants will be given an Psycho-physical well-being of plastic needles in the Spanish- patients throughout Europe and the EU: evaluation form based on Self-care in therapeutic adherence in women hemodialysis units the European Kidney Health Alliance model by Dorothea Orem, to assess with autosomal dominant polycystic Guillermo Pedreira-Robles (Spain) Raymond Vanholder (Belgium) patients’ skills to perform PD. kidney disease The participating groups will be asked Elena Brioni (Italy) to give their opinion about the evaluation form Maria Arminda Tavares (Portugal) O 35 O 41 Theoretical Module E-P 003 Patients and nurses perspectives about Balanced program obesity reduction Presenting guidelines and clinical The phenomenon of the burnout plastic cannulae for arteriovenous fistula kidney disease conducted by a nurse evidence about PD patient education. in nurses working in hemodialysis Rui Sousa (Portugal) specialized in physical activity Maria Arminda Tavares (Portugal) Alessandro Pizzo (Italy) Alícia Rovira (Spain) O 36 O 42 E-P 004 The nurse’s role in vascular access New pathways– improving knowledge Intradialytic exercise and season infection prevention and education to barriers to organ variations in haemodialysis patients Paula Cale (Portugal) donation and “opting out” Rui Camisa (Portugal) Neerja Jain (United Kingdom) O 37 O 43 E-P 005 Individualized cannulation technique Younger people are also accessing Individualized teaching to the dialysis centered to patient needs kidney supportive care patient Tânia Galhofas (Portugal) Ann Bonner (Australia) Célia Cunha (Portugal) SO 38 SO 44 E-P 006 Plastic versus metal cannulae The impact of Mediterranean Diet Patients self-care as promoter of quality in hemodialysis on biochemical markers of life: a case study Zorica Obric (Serbia) and cardiovascular risk factors in CKD Tânia Galhofas (Portugal) Vasiliki Zoi (Greece) SO 39 E-P 007 How to obtain a database for a vascular Impact of an exercise program access monitoring and surveillance on physical and mental health of regular programme? Hemodialysis patients Milene Cruz (Portugal) Boaventura Cabecinhas (Portugal) SO 40 E-P 008 Vascular surveillance program: Improvement on patient experience 18 months results and outcome with HDx dialyzer Catarina Santos Cunha (Portugal) Betty Choi (Canada) E-P 009 Impact of an intradialytic exercise program on body composition, phase angle and functional capacity Soraia Vieira (Portugal) E-P 010 Learning needs analysis: the 3rd survey Marie Richards (United Arab Emirates) 10:30–11:00 Coffee break – Monday, September 16th, 2019

19 Saturday Sunday Monday Tuesday

11:00–12:30 Hall A1 Hall A2 Hall A3 Tower 1 Tower 2 Aesculap Academy S 15 Parallel Session S 16 Parallel Session W 06 Workshop E-Poster Session B C 04 Course C 05 Course Vascular Access Peritoneal Dialysis Uncovering the power of extra-ordinary Chairs: Jeannette Finderup (Denmark) Violence & Aggression in Renal Care Critical states during a dialysis Chairs: Ruben Iglesias (Spain) & Irmina Chairs: Aase Riemann (The Netherlands) leadership – The leadership Challenge & Stavroula Vovlianou (Greece) Lector: Jaroslav Pekara (Czech Republic) treatment Vaicekauskyte (Lithuania) & Lynn Brown (Australia) Chair: John Sedgewick (United Kingdom) Lector: Michael Stern (Czech Republic) O 45 O 52 E-P 012 Must cannulation technique minimizes What type of dialysis better to choose Therapeutic compliance in haemodialysis cannulation site problems first? patients. Can nurses improve it? Rui Sousa (Portugal) Rachel Morgenstern (Israel) Valerio Neiviller (Italy) O 46 O 53 E-P 014 Preventive care of distal ischemia related Using UV-paint for evaluating touch- Online clearance monitoring (OCM with haemodialysis vascular access contamination of a patient-assistance Kt/V) vs. monthly laboratory Kt/V Andreia Silva (Portugal) device for peritoneal dialysis measurement in pediatric hemodialysis Sandra Neumann (Switzerland) patients Ana Grilo (Qatar) O 47 O 54 E-P 015 High-flow vascular access: the impact Successful peritoneal dialysis treatment Ambulatory blood pressure on the patient despite abdominal adhesions (a case study) in hemodialysis patients Elisa Amaral (Portugal) Iris Romach (Israel) Nopparat Maeboonruen (Thailand) O 48 SO 56 E-P 016 Are prosthesis segment interpositions Patient management in the vascular Dialysis disequilibrium syndrome in arteriovenous fistula producing good access failure: a case (emergency periton in incremental hemodialysis outcomes? dialysis) Niramon Wongyai (Thailand) Elisa Amaral (Portugal) Duygu Balci (Turkey) SO 49 SO 57 E-P 018 Ultrasound monitoring of the An improved CAPD submodality using The relationship between burnout buttonhole: creation of a classification a new assist device: CAAPD (Continuous and organizational commitment and assessment of its effectiveness Ambulatory/Automated Peritoneal among nurses working in nephrology Carolina Rubiella Rubio (Spain) Dialysis) departments Turkan Sanli (Turkey) Milana Haimovich (Israel) SO 50 SO 58 E-P 020 Resistance to Chlorexidine as needling Adapting teaching and learning Brown tumor as complication of severe site antiseptic agent, and frequent use methodologies following a training secondary hyperparathyroidism in Anna Marti i Monros (Spain) needs analysis hemodialysis patients: a case report Cathy Poole (United Kingdom) Mahmoud Ikteelat (Israel) SO 51 E-P 002 Doing rope-ladder or bottonhole that’s Estimating the prevalence of muscle the question? wasting, weakness and sarcopenia Lise Streubel-Kristensen (Denmark) in haemodialysis patients Clare McKeaveney (United Kingdom) 12:30–14:00 Lunch break – Monday, September 16th, 2019 Hall A1 Hall A2 Hall A3 Hall B S 17 Lunch Symposium W 07 Workshop Greek Forum – Hypertension in Chronic 12:45-13:45 Kidney Disease Gaining EDTNA/ERCA Accreditation 12:45-13:45 for your Renal Education Program – Chairs: Panagiota Tsougia, President What’s Involved of HENNA & Vasiliki Lagazali, Secretary Chairs: John Sedgewick (United of HENNA & Stavroula Vovlianou Kingdom) & Theodora Kafkia (Greece) (EDTNA/ERCA Brand Ambassador) (Session in Greek language)

Hypertension in Chronic Kidney Disease Vassilios Liakopoulos (Greece)

Blood Pressure measurement – technique data Marianna Eleftheroudi (Greece)

20 Saturday Sunday Monday Tuesday

14:00–15:30 Hall A1 Hall A2 Hall A3 Hall B Tower 1 Tower 2 S 18 Parallel Session S 19 Parallel Session W 08 Workshop – Physidia S 20 Parallel Session E-Poster Session C C 06 Course Haemodialysis 2 Caring for the Well-being of Renal Home Hemodialysis – Getting a better Join session ANNA-EDTNA/ERCA Chairs: Carlos Goncalves (Portugal) & Violence & Aggression in Renal Care Chairs: Anna Marti i Monros (Spain) & Healthcare Professionals quality of life for your patients Vascular Access: an International Marie Richards (United Arab Emirates) Lector: Jaroslav Pekara (Czech Republic) Hanadi Mezher (Lebanon) Chairs: Maria Arminda Tavares (Portugal) Chair: Irmina Vaicekauskyte (Lithuania) Perspective & Jeannette Finderup (Denmark) Chairs: Lynda K. Ball (ANNA Immediate Past President) & Maria Teresa Parisotto (EDTNA/ERCA Secretary) O 59 O 66 Principle benefits of home hemodialysis E-P 013 Investigation of comfort and some Exploring renal nurses’ attitudes and for renal patients Transition of care – quality improvement factors affecting patients with views to a patient’s decision to refuse Veliana Todorova (France) project in a hospital-based dialysis unit hemodialysis treatment dialysis treatment Iris Romach (Israel) Safiye Yanmış (Turkey) Mike Kelly (Ireland) O 60 O 67 Home hemodialysis – from the patient E-P 022 Investigation of effect on daily life The effect of working conditions perspective Transhepatic catheter access: a case activities and symptoms in hemodialysis on dialysis nurses’ health in Greece Aziz Abercane, Patient (France) study patients Chrysanthi Avrami (Greece) Virgínia Barroso Henriques (Portugal) Mukadder Mollaoğlu (Turkey) O 61 O 68 Home hemodialysis in practice E-P 023 Nurse led implementation of a safe Which factors influence the level Matt Willans (United Kingdom) The overhydration status of patients and effective hemoglobin control of nursing job satisfaction Greig Johnstone (United Kingdom) with arteriovenous graft thrombosis protocol in hemodialysis patients on haemodialysis private units? Cedric Poulard (France) Telmo Carvalho (Portugal) Michal Exman (Israel) Inês Agostinho (Portugal) Fredrik Thibblin (Sweden) SO 62 O 69 E-P 024 Nurses’ perspectives on patient Safety climate, safety behaviour and risk Physical examination of arteriovenous participation in hemodialysis treatments perception among nurses on dialysis fistula: how are we doing it and how Chava Kurtz (Israel) units to improve Mário Mateus (Portugal) Osvaldo Albuquerque (Portugal) SO 63 SO 70 E-P 025 Exploring the concordance Prevalence of musculoskeletal Development of nocturnal guidelines of malnutrition assessment tools complaints among haemodialysis nurses for home haemodialysis by special with the GLIM criteria among Magnus Lindberg (Sweden) interest group for home haemodialysis hemodialysis patients (SIGNhd-UK) Liana Poulia (Greece) Laura Thompson (United Kingdom) SO 64 SO 71 E-P 026 Systematic fluid assessment Unchanged nursing caretime for patients The relationship between LVEF in haemodialysis care: Development undergoing haemodialysis despite and renal function, blood pressure, and validation of a decision aid changes in characteristics over four years albumin, hemoglobin in CKD patients Jenny Stenberg (Sweden) Ria de Kleijn (The Netherlands) Nihal Khatib (Israel) SO 65 SO 72 E-P 027 The effect of patient compliance “My Chinese sister “ – Who takes care Monitoring vascular access with indirect on the phosphorus level in blood of the caregiver? methods Lyubov Kaurova (Russian Federation) Victoria Sura Zaslavski (Israel) Silvia Cappelletti (Italy) E-P 028 Usefulness of Stress Qb Test in vascular access surveillance. Results of a hemodialysis center Ana Catarina Brito Silva (Portugal) E-P 030 The use of an ultra-sound by nurses in Hemodialysis Unit: Benefits and Limitations Joana Ramos (Portugal) 15:30–16:00 Coffee break – Monday, September 16th, 2019

21 Saturday Sunday Monday Tuesday

16:00–17:30 Hall A1 Hall A2 Tower 1 S 21 Parallel Session S 22 Parallel Session E-Poster Session D Ethical, Psychological and Social Impact Open Forum 2 Chairs: Linsey Worsey (United Kingdom) of CKD Chairs: Jeannette Finderup (Denmark) & & Anna Klis (Poland) Chairs: Anastasia Liossatou (Greece) & Lynn Brown (Australia) Silvija Vladislavic (Croatia) O 73 O 80 E-P 031 Feasibility of a randomised controlled “Outstanding patient” competition Patient Safety Culture in a Hemodialysis trial of an arts-based intervention for among dialysis patients to promote clinic patients receiving haemodialysis adherence to treatment Ana Grilo (Qatar) Claire Carswell (United Kingdom) Lea Michaelashvili (Israel) O 75 O 81 E-P 032 Are chronic kidney disease patients Exploring the knowledge of non- How to re-incorporate nursing happy people? renal nurses regarding the nursing documentation in a new complex Catarina Sanha Cunha (Portugal) management of in-patient hemodialysis electronic healthcare recording system patients Anne Marie Boeskov (Denmark) Freddie Costales (United Arab Emirates) SO 76 O 82 E-P 033 “Hope” – a multidimensional concept in Haemodialysis nurses’ confidence in Factors influencing postural balance in nursing care carrying out a comprehensive renal haemodialysis patients Virgínia Barroso Henriques (Portugal) physical assessment: a pilot project Ana Lino (Portugal) Jerel Kim Laguardia (United Arab Emirates) SO 77 O 83 E-P 034 Quality of life of dialysis patients and Nursing case manager in a haemodialysis A review of comprehensive discharge treatment regime adherence unit: the way to improve planning to patients with new onset Ana Sofia Gomes (Portugal) Pedro Gonçalves (Portugal) diabetes after transplantation Gitte Marie Erdmann (Denmark) SO 78 SO 84 E-P 035 Perception of the patients’ quality of life Providing mindfulness meditation to Multidisciplinary treatment of during the first year of dialysis treatment patients with end stage kidney disease- a calciphylaxis injury Carina Gonçalves (Portugal) overview of best practice Hugo Costa Azevedo (Spain) Clare Mc Veigh (United Kingdom) SO 79 SO 85 E-P 036 Investigation of fatigue and some factors Evaluation of the efficiency of hygiene Benefits of Kidney transplant in frailty affecting patients with chronic kidney and infection control trainings in patient disease hemodialysis centers Maria Vera Casanova (Spain) Esra Başer (Turkey) Fatma Kaban (Turkey) SO 86 E-P 037 Timely referral to angioplasty due to FMEA- small act can save – or cost – arteriovenous fistula maturation failure a life Telmo Carvalho (Portugal) Muhammad Khaskiya (Israel) E-P 038 Nursing interventions to prevent infections in Peritoneal Dialysis patients – literature review Maria Arminda Tavares (Portugal)

22 Saturday Sunday Monday Tuesday

Tuesday, September 17th, 2019 08:30–10:00 Hall A1 S 23 Plenary Session CKD & Conservative Renal Care Chairs: Evgenia Golland (Israel) & Reem Alhameedi (Saudi Arabia) Guest Speaker lecture The Older Dialysis Patient: Issues and Concerns Alice Hellebrand (United States) O 87 Kidney supportive care: Evaluation of treatment decision-making and advance care plans Ann Bonner (Australia) O 88 Palliative care needs in chronical kidney disease on regular haemodialysis patients Tatiana Silva (Portugal) SO 89 Last days of hepatitis C virus Péter Kabai (Hungary) SO 90 Development and introduction of a mentorship learning program for renal nurses Lynn Brown (Australia) SO 91 Psychosocial experiences of patients with end stage kidney disease: a phenomenological study Miriam Carole Atieno Wagoro (Kenya) 10:00–10:15 Coffee break – Tuesday, September 17th, 2019 10:15–11:45 Hall A1 S 24 Plenary Session Risk Management Chairs: Tai Mooi Ho Wong (Spain) & Marisa Pegoraro (Italy) O 92 The effect of a balance exercise programme on haemodialysis patients Ana Furtado (Portugal) O 93 Factors influencing incidence of falls in haemodialysis patients Hugo Oliveira (Portugal) SO 94 Factors that influence the patient’s perception of safety during haemodialysis Ana Catarina Pereira (Portugal) SO 96 Break the barriers on hand hygiene in a haemodialysis unit Marta Coimbra (Portugal) SO 97 Good practice guide to prevent dissemination of infection by Klebsiella pneumoniae-carbapenemase in haemodialysis center Esmeralda Nunes (Portugal) 11:45–12:00 Break – Tuesday, September 17th, 2019 12:00–13:00 Hall A1 S 25 Closing Ceremony Welcome to the Closing Ceremony Conference Overview Poster Award voted by the Conference Delegates Speaker Award voted by the Conference Delegates The 49th EDTNA/ERCA International Conference, 2020 Closing of the 48th EDTNA/ERCA Conference

23 LIST OF E-POSTERS

Conservative Renal Care E-P 041

Education E-P 042 – E-P 043; E-P 045 – E-P 049

Ethical, Psychological and Social Impact of CKD E-P 050

Haemodialysis E-P 051 – E-P 058; E-P 060 – E-P 062; E-P 064; E-P 103

Home Therapies E-P 065; E-P 104

Multimorbidity in Renal Care E-P 067

Nutrition E-P 072

Open Forum E-P 073 – E-P 076

Peadiatric Renal Care E-P 077

Peritoneal Dialysis E-P 078 – E-P 080; E-P 082 – E-P 083

Risk Management & Quality Improvement E-P 084 – E-P 088; E-P 091

The Patient Experience E-P 092 – E-P 094

Transplantation E-P 095 – E-P 099; E-P 101 – E-P 102

Vascular Access E-P 099 – E-P 102

24 CONSERVATIVE RENAL CARE

E-P 041 Renal nurse practitioner leadership in renal supportive care S. Russo Nephrology, Hunter New England local health district, Newcastle, Australia

EDUCATION

E-P 042 Education and training: impact of phosphate binders compliance P. Alejandre Malda, M. Vicario Marquegui, F. J. Lopez Sanchez, J. Madarieta Juaristi, X. Perez Saenz Azkunaga, J. Sanchez Jimenez Nephrocare- Bilbao dialysis center (Dialbilbo), Bilbao, Spain

E-P 043 Using the spiral curriculum model to improve record keeping in satellite haemodialysis units C. Poole, C. Hutchinson, M. Starr, B. Brierley Training & Education, Fresenius Medical Care, Birmingham, United Kingdom

E-P 045 Applying strategy to promote, support and monitor improvements in hand hygiene compliance in haemodialysis G. Dewsnap, G. Cater, N. Ward, N. Beddows, C. Poole Nephrocare Head Office, Fresenius Medical Care, Kings Norton, Birmingham, United Kingdom

E-P 046 Education and Decision Support for Unplanned Start Patient Z. Aydin1, S. Ozcan2 1Health Science Institute, Koc University, Istanbul, Turkey;2 Nursing Faculty, Koc University, Istanbul, Turkey

E-P 047 Evaluating the effectiveness of patient education methods F. Kaban1, E. Dane2, D. Yalçın3, N. Burbut4, Ö. Usul4, B. Yılmaz4, H. Kaptanogulları5 1Training Coordinator, Vocational School of Health Services- Dialysis Department, Lecturer, Medikare Dialysis Centers, Biruni University, Istanbul, Turkey; 2Vocational School of Health Services- Dialysis Department, Lecturer, Acibadem University, Istanbul, Turkey; 3Vocational School of Health Services- Dialysis Department, Lecturer, Istanbul Bilim University, Istanbul, Turkey; 4Registered Mentor Nurse, Medikare Dialysis Centers, Istanbul, Turkey; 5Chairman- Vocational School of Health Services- Dialysis Department, Academic member, Medikare Dialysis Centers, Biruni University, İstanbul, Turkey

E-P 048 Development of a patient education system in our dialysis clinic T. Farkas Dialysis Centre, Fresenius Medical Care, Sátoraljaújhely, Hungary

E-P 049 Training for daily home hemodialysis – psychological aspects F. Delestre, C. Montet Nephrologie et Dialyses, Hopital Tenon, Paris, France

ETHICAL, PSYCHOLOGICAL AND SOCIAL IMPACT OF CKD

E-P 050 Where do you perform your CAPD exchange? S. Vladislavic Department of nephrology and hemodialysis, University Hospital Split, Split, Croatia

HAEMODIALYSIS

E-P 051 The dependence of compliance on the cognitive functions of patients on chronic haemodialysis R. Arslanova1, I. Bastrykina1, O. Portnova2, M. T. Parisotto3 1Fresenius Medical Care, Fresenius NephroCare Dialysis Centre, Volgograd, Russian Federation;2 Fresenius Medical Care, Fresenius NephroCare department, Moscow, Russian Federation;3 Fresenius Medical Care, Care Value Management, Bad Homburg, Germany

E-P 052 Prevalence of obesity and evaluation of adequacy among this population during last 5 years V. Ionita Hemodialysis, Fresenius NephroCare, Bucharest, Romania

25 E-P 053 Synthetic vascular graft an alternative to arteriovenous fistula A. Necula Hemodialysis, Fresenius NephroCare, Bucharest, Romania

E-P 054 The challenging journey of pregnancy and dialysis: Challenge for patient and staff R. Naim, Z. Gavish, I. Bogner, I. Rafaelov-Atias, J. Plotkin Nephrology, Rambam – Health Care Campus, Haifa, Israel

E-P 055 “Give light and people will find the way-” spiritual support for dialysis patients R. Dahan, Z. Gavish, E. Kruzel-Davila Nephrology, Rambam-Health Care Campus, Haifa, Israel

E-P 056 Centered pproach – dialysis patient to Type 1 diabetes with eating disorders, anxiety and depression G. Maximov Hemodialysis Unit. Nephrology., Sheba (Tel Hashomer) Medical Center, Ramat Gan., Israel

E-P 057 HemoControl resolving intra dialysis hypotension M. Drazeta, Z. Obric Hemodialysis, Clinical hospital centre Zemun – Belgrade, Zemun, Serbia

E-P 058 Pregnancy in women on hemodialysis I. Mahamid Nehrology, Nephrolife, Tel Aviv Medical Centre, Umm el Fahem, Israel

E-P 060 Comparison of self-care ability and life satisfaction of patients receving dialysis and healthy individuals C. Dogan1, A. Karakoc1, F. Turan1, A. Ozturk1, D. Ates1, F. Semercı2, M. Yılmaz1, N. O. Harmankaya1 1Dr.Sadı Konuk Traınıng and Research Hospıtal, Istanbul, Turkey; 2Medıkare Dıalysıs Center, Istanbul, Turkey

E-P 061 Choosing a treatment for kidney failure S. Stiperski Nefrology, KBC Zagreb, Zagreb, Croatia

E-P 062 Change in compliance in a pregnant patient on chronic dialysis program. A case report Z. É. Nagy, B. Thomas, J. Mátyus, J. Balla, V. Batthány Dialysis Centre, Fresenius Medical Care, Debrecen, Hungary

E-P 064 Role of blood pressure monitoring to determine optimal body weight of hyperhydrated acute patients E. Pintér, S. Keresztesi Dialysis Centre, Fresenius Medical Care, Kecskemét, Hungary

E-P 103 Comparison of self-care ability and life satisfaction in patients receiving dialysis C. Dogan1, A. Karakoc1, F. Turan1, A. Ozturk1, D. Ates1, F. Semercı2, M. Yılmaz1, N. O. Harmankaya1 1Dr. Sadı Konuk Traınıng and Research Hospıtal, Istanbul, Turkey; 2Medıkare Dıalysıs Center, Istanbul, Turkey

HOME THERAPIES

E-P 065 Why and how often need hospital based hemodialysis session the home hemodialysis patients? A. Marti, D. Gacho, B. Lazaro, A. Bonilla, J. Gonzalez Nephrology, Consorcio Hospital General Univesitario Valencia, Valencia, Spain

E-P 104 The Journey Home: Growing a home hemodialysis program while fostering professional relationships K. Brown, K. Clarke Home Hemodialysis, Peterborough Regional Health Centre, Peterborough, Ontario, Canada

26 MULTIMORBIDITY IN RENAL CARE

E-P 067 Analysis of lethal outcomes in patients on RRT and the identification of risk factors I. Budakova1, O. Portnova2, M. T. Parisotto3 1Fresenius Medical Care, Fresenius NephroCare Dialysis Centre, Stary Oskol, Russian Federation;2 Fresenius Medical Care, Fresenius NephroCare department, Moscow, Russian Federation;3 Fresenius Medical Care, Care Value Management EMEA, Bad Homburg, Germany

NUTRITION

E-P 072 A kitchen „renal dietary” course for chronic kidney disease patients and quality nutrition support L. Góz, B. Thomas, J. Balla Dialysis Centre, Fresenius Medical Care, Debrecen, Hungary

OPEN FORUM

E-P 073 Human resource management of renal nursing staff: The case study of Northern Greece S. Vovlianou1, N. Nikiforidou1, S. Zekaki2, E. Dimitriadis3 1Renal Unit, General Hospital of Kavala, Kavala, Greece; 2Director of Nursing Service, General Hospital of Kavala, Kavala, Greece; 3President of the Nursing Department, Eastern Macedonia and Thrace Institute of Technology, Kavala, Greece

E-P 074 Fibromuscular displasia – case report M. Mihalić, Ž. Dika Division of Nephrology, Arterial Hypertension, University Hospital Centre Zagreb, Zagreb, Croatia

E-P 075 Treatment of West Nile Fever virus infection by plasmapheresis M. Németh, I. Papp, J. Balla Dialysis Centre, Fresenius Medical Care, Debrecen, Hungary

E-P 076 Haemodialysis and peritoneal dialysis from nursing aspect. Difficulties and differences due to experience F. Gerhák, S. Keresztesi Dialysis Centre, Fresenius Medical Care, Kecskemét, Hungary

PEADIATRIC RENAL CARE

E-P 077 Successful treatment of hyperlipidemia with plasmapheresis – case report S. Besedic Referal Center for nephrology, dialysis and transplantation, University Hospital Center Zagreb, Zagreb, Croatia

PERITONEAL DIALYSIS

E-P 078 Dramatic and symptomatic decline in renal function – rapid start peritoneal dialysis (PD)? K. Dailey, S. Morgan, K. Wong, J. Uy Renal Medicine, Royal Prince Alfred Hospital, Sydney, Australia

E-P 079 Anthropoplicometric measurements in peritoneal dialysis patients C. Sayan1, L. Yucel1, Y. Deligoz Bildaci2, A. S. Artan2, O. C. Elcıoglu2, E. Haziyev2, M. Gursu2, R. Kazancioglu2 1Hemodialysis and Peritoneal Dialysis Unit, Bezmialem Vakif University Medical Faculty, Istanbul, Turkey; 2Nephrology, Bezmialem Vakif University Medical Faculty, Istanbul, Turkey

E-P 080 The effect of peritoneal dialysis on balance and falling risk D. D. Balci1, D. Efeyurtlu1, A. Inci2, S. Gul2, A. M. Sarikaya2, M. Bilgilisoy Filiz3, S. Koldas Dogan3, F. Sari4 1Peritoneal Dialysis, Health Sciences University Antalya Training and Research Hospital, Antalya, Turkey; 2Nephrology, Health Sciences University Antalya Training and Research Hospital, Antalya, Turkey; 3Physical Therapy and Rehabilitation, Health Sciences University Antalya Training and Research Hospital, Antalya, Turkey;4 Nephrology, Akdeniz University Medical School Hospital, Antalya, Turkey

27 E-P 082 Patients with high body mass index in peritoneal dialysis program T. Vargáné Szabó, S. Keresztesi Dialysis Centre, Fresenius Medical Care, Kecskemét, Hungary

E-P 083 Does the fast peritoneal equilibration test replace the standart peritoneal equilibration test? A. Ozturk, D. Ulu, A. Karakoc, F. Turan, N. O. Harmankaya, M. Yılmaz, F. Kocak, A. Ozdemır Dr. Sadi Kouk Training and Research Hospital, Istanbul, Turkey

RISK MANAGEMENT & QUALITY IMPROVEMENT

E-P 084 Nephrological nurses and occupational exposure – how? when? why? A. Trzcińska1,2,3 1Medical University of Silesia, Katowice, Poland; 2Polish Nephrology Nurses Association, Katowice, Poland; 3Polish Vascular Access Club, Katowice, Poland

E-P 085 Quality management system in a haemodialysis unit and patient satisfaction A. Kavalieratou, G. Garofyllou Haemodialysis Unit, Konstantopoulio G.H. N. Ionia, Athens, Greece

E-P 086 Less is more – quality improvement through simplification K. Dailey, D. Davison Department of Renal Medicine, Royal Prince Alfred Hospital, Sydney, Australia

E-P 087 Introducing a falls risk assessment tool within the satellite haemodialysis unit setting G. Cater, N. Beddows, G. Dewsnap, N. Ward, C. Poole Fresenius Medical Care Renal Services Ltd, Kings Norton, Birmingham, United Kingdom

E-P 088 Improving correct hand hygiene compliance in dialysis unit R. Hais Hemodialysis, Assuta medical center, Haifa, Israel

E-P 091 Smart software application used in dialysis clinics – Workforce Management C. Popescu, M. Preda Medical, Fresenius Medical Care Romania, Bucharest, Romania

THE PATIENT EXPERIENCE

E-P 092 Travelling and Haemodialysis A. Kavalieratou, G. Garofyllou Haemodialysis Unit, Konstantopoulio G.H. N. Ionia, Athens, Greece

E-P 093 Is dialysis adequacy the determinant factor for the successful assessment of a treatment? V. Zoi, N. Piliouras, A. Maniati, D. Siopi, V. Marinopoulou Dialysis Unit, ATTIKON University Hospital, Haidari, Athens, Greece

E-P 094 The conscious decision of haemodialysis discontinuation in elderly and the nurse’s aspect V. Zoi, N. PIliouras, M. Flevotomou, E. Bathra, V. Kiriakidis, V. Marinopoulou Dialysis Unit, ATTIKON University Hospital, Haidari, Athens, Greece

TRANSPLANTATION

E-P 095 National transplant program in Montenegro D. Pelicic1, 2, M. Ratkovic3, 2, D. Radinovic3, B. J. Nikolina4, 5 1Center for Science, Clinical Center of Montenegro, Podgorica, Montenegro; 2Faculty of Medicine, University of Montenegro, Podgorica, Montenegro; 3Clinic for Nephrology, Clinical center of Montenegro, Podgorica, Montenegro; 4Department of nephrology, arterial hypertension, dialysis and transplantation, University Hospital Centre Zagreb, Zagreb, Croatia; 5School of Medicine, University of Zagreb, Zagreb, Croatia

28 E-P 096 Kidney transplant – a case study and dilemmas. What is right and what is wrong? I. Rafaelov Atias, M. Shem Tov Alisha, Z. Gavish, R. Asulin Nephrology, Rambam-Health Care Campus, Haifa, Israel

E-P 097 Assessment of health-related quality of life in kidney transplant recipients vs dialysis patients V. Koutlas1, M. Ikonomou2, E. Tzalavra1, Z. Delimitsou2, C. Pappas2, M. Mitsis1, E. Dounousi2 1Department of Surgery – Kidney Transplant Unit, University Hospital of Ioannina, Ioannina, Greece; 2Department of Nephrology, University Hospital of Ioannina, Ioannina, Greece

E-P 098 Dental care in dialysis and transplant patients H. Klaric, Ž. Lubina, Ž. Lubina University Hospital Zagreb, Zagreb, Croatia, Department for Nephrology, AH, Dialysis and Transplantion, Zagreb, Croatia

VASCULAR ACCESS

E-P 099 From the creation of a new AVF to full performances, our experience G. Radakovic, S. Jandric International Dialysis Centre Banja Luka, Fresenius Medical Care Bosnia and Herzegovina, Banja Luka, Bosnia and Herzegovina

E-P 101 Assessment of the knowledge hemodialysis patients have of the arteriovenous fistula and its care M. Lukoševičienė, J. Kristopaitiene B|Braun Avitum, Vilnius, Lithuania

E-P 102 Applying of rope ladder puncture technique in our dialysis network R. Mogyorósi, K. Hohmann Dialysis Centre Ltd., Fresenius Medical Care, Budapest, Hungary

29 THE EXHIBITION FLOOR PLAN

List of Exhibitors 1a Fresenius Medical Care 5 Open area 11 Emodial 1b Fresenius Medical Care 6 NxStage 12 EDTNA/ERCA 2 B.Braun 7 Diaverum 13 Medow 3 Medtronic 8 Tauropharm 14 Peripal 4 IHT – Innovative Health 9 Physidia Technologies 10 Diasoft

30 THE EXHIBITORS

B. Braun Avitum AG A family-owned company founded in 1839 in Melsungen, Germany, B. Braun today is one of the world‘s leading healthcare companies with more than 63,000 employees working in 64 countries. The product range includes dialysis machines and dialysis consumables for chronic dialysis and acute dialysis. In addition to its role as a manufacturer of dialysis equipment, B. Braun is also an important provider of dialysis treatment. B. Braun operates more than 370 renal care centers. Additional care services such as holiday dialysis and pre-dialysis programs are offered in most markets.

Address: Am Buschberg 1, Melsungen, Hessen, 34212, Germany Contact Person: Vanessa Hoehle Website: www.bbraun-dialysis.com

Diasoft MISSION – Our mission is to develop a patient care IT system for renal patients. In order to increase the quality of treatment and out of respect for each individual human being, Diasoft created and maintains a safe .CORE VALUES – Respect for each individual | Focus on safety and privacy | Professional and independent in handling data | Dedicated to improve the quality of treatment | Easy to approach. QUALITY – Diasoft meets the medical requirements and safety standards and is a CE marked medical device. To guarantee the highest level of safety for the patient and the user, the software Diamant is classied as a Class II B device. This guarantees the highest level of patient safety. Diasoft has a certied Quality Management System compliant with ISO 13485:2016 and ISO 9001:2015 and an integrated Information Security Management System conform ISO 27001:2013.

Address: Klepelhoek 11, Leusden, Netherlands, 3833 GZ Contact person: Nicole van Rooijen Website: https://diasoft.nl/

DIAVERUM Diaverum is Europe’s largest product-independent renal care service providers and one of the world leaders in this ’ experience in the area of dialysis. The high focus on medical quality, care management and the treatment of kidney disease, as well as its individual patient care focus, makes Diaverum unique. Today, 11,000 employees care for more than 36,000 patients in 20 countries in its 380 centres located in Europe, South America, Africa and Asia. Diaverum has its roots in Sweden. For further information, please visit our website: www.diaverum.com

Address: Hyllie Boulevard 39, Malmö, SE 215 37, Sweden Contact Person: Michaela Blomstrand Website: www.Diaverum.com

31 EMODIAL Since its foundation, Emodial has been committed to develop what we call the “therapeutical alliance”, a model based on the direct cooperation between the main actors of the vascular access scenario: doctors, nurses, patients, patients associations, caregivers. Starting from the direct experience of patients, which Emodial collects through dialogue with them and with patient associations, the aim is to create solutions to accomplish its mission and its promise: improve the patient‘s quality of life, raise healthcare standards, contain and optimize healthcare spending and reduce healthcare time and risks associated with it. Emodial develops advanced solutions for the vascular access management in hemodialysis, oncology, intensive care and parenteral nutrition: the Silver line of pads, plasters and pockets for CVCs, peritoneal catheters and PICCs releasing silver ions with antibacterial and anti- in pockets for catheter, for bath and shower.

Address: VIA G. FINATI 4/A, Ferrara, 44124, Italy Contact Person: Patrizia Cozzolino Website: www.emodial.it

Fresenius Medical Care Deutschland GmbH Fresenius Medical Care is the world’s leading provider of products and services for people with chronic kidney failure. We care for more than 336,000 patients in our global network of more than 3,900 dialysis clinics. At the same time, we operate 42 production sites on all continents, to provide dialysis products such as dialysis machines, dialyzers and related disposables. Along with this core business, Fresenius Medical Care provides related medical services in the Creating a future worth living. For patients. Worldwide. Every day. This vision guides us in our efforts to give our patients around the world a better life by offering them high-quality products and outstanding health care. In NephroCare, the international dialysis care provider network of Fresenius Medical Care, we developed our recipe for success to deliver value in renal care, for patients and for healthcare systems.

Address: Else-Kröner-Str. 1, Bad Homburg v.d.H., 61352, Germany Contact Person: Kerstin Beyer Website: www.freseniusmedicalcare.com

Innovative Health Technologies IHT (Iberhospitex, S.A.) is a European company, based in Barcelona, with over 38 years of experience in healthcare technologies (1980–2018). We market our products worldwide. Our aim is to continue manufacturing high quality products, focusing particularly on dressings for wound treatment and skin care (Skin & Wound Care Business Unit) and less invasive treatment for cardiovascular disease (Cordynamic Business Unit).

Address: Avinguda Catalunya, 4, Lliçà de Vall, Barcelona, 08185, Spain Contact Person: Dolors Cañete de Cárdenas Website: www.iht.es

32 MEDOW Medow develops innovative health care products that bring eciency, comfort and joy by using design and colour. Our aim is to create a better health care by finding the small problems where our solutions will make a big difference. Medow’s first product IV-bracelet, is an easy to use bracelet to which blood lines can be attached to keep them and needles in place during dialysis treatments. The bracelet gives the patients a safe and comfortable treatment and at the same time eases the nurses’ work.

Address: Revingegatan 15 A, Lund, 22356, Sweden Contact Person: Frida McCabe Website: https://medow.se/

Medtronic As a global leader in medical technology, services and solutions, Medtronic improves the health and lives of millions of people each year. We believe our deep clinical, therapeutic and economic expertise can help address the complex challenges — such as rising costs, aging populations and the burden of chronic disease – faced by families and healthcare systems today. But, we cant do it alone. That’s why we’re committed to partnering in new ways and developing powerful solutions that deliver better patient outcomes. Founded in 1949 as a medical repair company, we’re now among the world’s largest medical technology, services and solutions companies, employing more than 85,000 people worldwide, serving physicians, hospitals and patients in more than 160 countries. Join us in our commitment to take healthcare Further, Together. Learn more at Medtronic.com.

Contact Person: Andrea Fuskova Website: Medtronic.eu

NxStage Medical, Inc. NxStage Medical, Inc. is a leading medical technology company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease (ESRD) and acute kidney failure. NxStage also has established a small number of dialysis clinics committed to the development of innovative care delivery models for patients with ESRD.

Address: 350 Merrimack Street, Lawrence, MA 01843 Contact Person: Colleen Moore Website: www.nxstage.com

Peripal AG Peripal AG is a privately funded start-up from the ETH Zürich and the medtech industry. It‘s CE-marked innovation PeriSafe® is available for patients in EU countries and can help them to perform their daily peritoneal dialysis daily therapy at home. It guides the catheter connection without manual contact with the dialysis tubing and enables more patients to receive their therapy at home. Compared to hospital-based treatment, this would result in considerable healthcare cost reductions worldwide.

Address: Limmatquai 112, Zürich, 8001, Switzerland Contact Person: Martin Dubach Website: www.peripal.com

33 Physidia Physidia is a French company created in 2010, with an expertise in the development, manufacturing and distribution of innovative technology for daily home dialysis. Physidia is present today in 16 countries, operating directly in France and The United Kingdom and through distributor partners in the rest of Europe. Physidia’s innovations are based on several technological breaking points, offering a robust, portable and connected device, whilst ensuring a performing treatment in total autonomy. Created by an expert team, Physidia S3 monitor has been specifically developed to respond to the needs of simplicity and safety of ESRD patients in home hemodialysis.

Address: 11–13, . des Bretonnières, Saint-Barthélémy d’Anjou, 49124, France Contact Person: Veliana Todorova Website: www.physidia.fr

TauroPharm GmbH TauroPharm GmbH is a life science company specialized in antimicrobial medical devices. One of the company’s core interests is to offer a safe and effective technology for locking central venous access devices (catheters and ports). TauroLock™, a non-antibiotic lock solution, which is capable of dramatically reducing catheter related blood stream infections (CRBSI) is free of side-effects. The active compound is taurolidine which is not an antibiotic, but a derivative of an amino acid. TauroLock™ is highly effective in eradicating bacteria and fungi and has been successfully tested on more than five hundred organisms, including multi resistant forms such as MRSA and VRE. It is to be used in dialysis, oncology, intensive care and parenteral nutrition. To improve catheter patency TauroLock™ products contain 4% citrate and in addition heparin or urokinase.

Address: August-Bebel-Str. 51, Waldbüttelbrunn, 97297, Germany Contact Person: Kerstin Bachmann Website: www.taurolock.com

The organizers would like to express their thanks to Prague for it’s support

34 35 PRACTICAL CONFERENCE INFORMATION

Conference Badges Each Conference delegate will receive a Conference badge upon registration. The Conference badge must be worn during the entire Conference to be able to enter the Scientific Sessions and receive education accreditation. On your badge there is a barcode which will be scanned when entering and leaving each session hall.

Credits will be assigned according to the information received from the barcode system. This information is also used for safety reasons to register participants who are in the building in case of emergency. Therefore, it is important you present your badge at each session hall.

48th EDTNA/ERCA 48th EDTNA/ERCA 48th EDTNA/ERCA 48th EDTNA/ERCA 48th EDTNA/ERCA 48th EDTNA/ERCA Interna onal Conference Interna onal Conference Interna onal Conference Interna onal Conference Interna onal Conference Interna onal Conference Prague, Czech Republic Prague, Czech Republic Prague, Czech Republic Prague, Czech Republic Prague, Czech Republic Prague, Czech Republic September 14th-17th, 2019 September 14th-17th, 2019 September 14th-17th, 2019 September 14th-17th, 2019 September 14th-17th, 2019 September 14th-17th, 2019

ENTRANCE EXIT ENTRANCE EXIT

DELEGATE DELEGATE VOLUNTEER ACCOMPANY STAFF HOSTESS SETSUP CREW PERSON

48th EDTNA/ERCA 48th EDTNA/ERCA 48th EDTNA/ERCA 48th EDTNA/ERCA 48th EDTNA/ERCA Interna onal Conference Interna onal Conference Interna onal Conference Interna onal Conference Interna onal Conference Prague, Czech Republic Prague, Czech Republic Prague, Czech Republic Prague, Czech Republic Prague, Czech Republic September 14th-17th, 2019 September 14th-17th, 2019 September 14th-17th, 2019 September 14th-17th, 2019 September 14th-17th, 2019

ENTRANCE EXIT

DISMANTLING CREW EXHIBITOR PRESS GUEST GUEST SPEAKER

Coffee Breaks Coffee & tea will be provided during breaks. Lunch boxes will be provided on Sunday, September 15th and Monday, September 16th at lunch time breaks.

Internet WiFi is free of charge, no password needed Network: EDTNA/ERCA_CUBEX

Insurance The Conference organizer cannot accept liability for personal injuries sustained or for loss or damage of property belonging to Conference participants, either during or as a result of the Conference. Please check the validity of your own insurance.

Conference Language The Conference is being organized by an International Association with the goal of Education and Science. All oral presentations and posters must be in English. Special sessions might be organized in languages other than English and without translation. All hostesses and Conference staff speak English and other languages.

Sessions held in the main hall will be simultaneously translated from English into Czech.

The Team of EDTNA/ERCA Our Team from the Secretariat, Membership & Conference Department will be available at the Registration Desk and in the EDTNA/ERCA booth to support you during the entire Conference.

Posters E-Poster Stations are located on the 1st floor in the Exhibition Area.

36 Photo and Video Participants are kindly reminded that taking photos and videos is prohibited at all oral presentations to reduce disruptionfor speakers and the audience. Delegates, exhibitors, sponsors, speakers and any other registered attendees of the 48th EDTNA/ERCA International Conference, Prague, Czech Republic, September 14th–17th, 2019 acknowledge the information that pictures, videos and sound documents are taken during the Conference on behalf of EDTNA/ERCA (Organizer), and may be stored, used or published for Conference Reports and/or future information to members and interested renal community. It shall be clear to attendees that photographs, sound or video recordings taken during the conference will include recognizable images or voices of those in attendance and that such material may be made available on the Associations website or may be posted in Social Media communicating about the Conference. As EDTNA/ERCA we do not prohibit participants, exhibitors, sponsors or media from photographing, video- or audio-taping some Conference activities. EDTNA/ERCA is not responsible for third party use of such materials. Any individual has the right to deny participation in photographs, video or audio recordings. A person always has the right to revoke any consent given for use and may ask to get complete information on such personal data filed and stored and can ask that audio-visual data on the person is deleted. The ownership remains at all times with the person on pictures or on voice or video recorded material. https://www.edtnaerca.org/resource/edtna/files/General_Terms_and_Conditions.pdf

REGISTRATION FEES – ONSITE

EUR Net EUR VAT 21 % EUR Total Category of VAT ** incl. VAT 21 % Member *** 471,07 98,93 570,00 Non-member 574,38 120,62 695,00 Student* 223,14 46,86 270,00 Student Fee* for MEMBERS 123,96 26,04 150,00

Note: * Student fee is applicable until the age of 26 years; students shall submit a document of their school or university proving the age and student status when they register. ** Participant fees are subject to 21% of Czech VAT, payable as NET plus VAT. EDTNA/ERCA VAT registration is in process; taxable invoices are made after April 1st, 2019 only. *** Members may not apply for the Member Participant Fee if they are not a current member. To become a member, register here: EDTNA/ERCA General member registration form. After July 15th a registration as NEW member is not possible. *** Global Members shall register at the Member Participant Fee; Conference Members 2018 shall register at the Non-Member Fee.

37 OPENING HOURS SUMMARY

Registration All documents, personal name badge and Conference bag will be handed out to registered participants during the following opening hours SATURDAY, September 14th, 2019 08:00–20:00 SUNDAY, September 15th, 2019 08:00–18:00 MONDAY, September 16th, 2019 08:00–18:00 TUESDAY, September 17th, 2019 08:00–14:00

Speakers’ Ready Room SATURDAY, September 14th, 2019 12:00–20:00 SUNDAY, September 15th, 2019 08:00–18:00 MONDAY, September 16th, 2019 08:00–18:00 TUESDAY, September 17th, 2019 07:30–13:00

Exhibition SATURDAY, September 14th, 2019 19:30–22:00 SUNDAY, September 15th, 2019 08:30–17:30 MONDAY, September 16th, 2019 08:30–17:30

GOOD TO KNOW ABOUT PRAGUE

More information about Prague can be find on https://www.prague.eu/en/practical or https://www.edtnaerca.org/resource/edtna/files/EDTNA_ERCA_2nd_Announcement_Prague_2019.pdf

38 CONFERENCE CONTACTS

EDTNA/ERCA Secretariat & Membership Management Högs Byväg 118 SE-246 55 Löddeköpinge Sweden Phone: + 46 46 70 96 24 E-mail: [email protected]

EDTNA/ERCA Conference, Marketing, Industry Relations, Exhibition & Sponsorship Mrs. Anki Davidson Marketing Director P&B – Presentation & Branding AB Källstorps Gård Högs Byväg 118 S-246 55 Löddeköpinge Sweden Phone: +46 46 70 96 24 Mobile: +46 721 94 00 10 E-mail: [email protected]

EDTNA/ERCA Conference Department & Registrations GUARANT International spol. s r.o. Na Pankráci 17 CZ-140 21 Prague 4 Czech Republic Phone: +420 284 00 14 44 Fax: +420 284 00 14 48 E-mail: [email protected]

EDTNA/ERCA Head Office Seestrasse 91, CH 6052, Hergiswil, Switzerland, UID CHE 498.689.154

JURISDICTION The place of jurisdiction is Stans, Switzerland

39 49th EDTNA/ERCA International Conference September 12th - 15th, 2020 Ljubljana, Slovenia

Conference Theme Knowledge, Skills & Commitment - Core Elements to Manage Care

Abstract Submission deadline - January 17th, 2020

PRESIDENTS MESSAGE It is with great pleasure and pride that we invite you to join us in Ljubljana where our 49th EDTNA/ERCA International Conference, September 12th - 15th, 2020 will take place. Ljubljana is Slovenia’s capital and largest city and it’s known for its university population and green spaces.

The EDTNA/ERCA is a multidisciplinary organization for those working in renal care. Through the Scientific Programme we offer a significant and valuable contribution to the care by Workshops, Courses and Educational Sessions. The Conference is a forum for sharing best research and innovations in practice and helps initiating and promoting quality renal research and practice around the world. It also has an important role of educating, exchanging information and experience, utilizing the expertise of healthcare professionals, service leaders, academics, researchers, care givers, people with renal disease and industry partners. Delegates from around 70 countries, who come together to share experience, innovations and knowledge.

We are very much looking forward to Welcoming you to Ljubljana! With warm regards,

Edita Noruišienė EDTNA/ERCA President

www.edtnaerca.org/conferences